BPC-157 works through at least six distinct molecular pathways simultaneously
Endothelial apoptosis, membrane abnormalities, and mitochondrial damage are all features of systemic inflammation induced by BBB disruption [67, 71]
The cross-talk and feedback loops between BDNF and the NMDAR signalling was reviewed by Georgiev et al (71)
There is little clinical guidance on this, so pharmacists must prioritise patient safety and, since there is no validated dose equivalence, the safest approach is to start the new medication its lowest available dose then titrate gradually per standard schedule
Here is a framework for developing your own optimized schedule
Further studies are needed to confirm the actual benefit of this molecule on metabolic liver diseases and define the best route of administration and the most appropriate dosage, allowing its use in clinical practice